The response of cells to mechanical force 1-3 is a major determinant of cell behaviour and is an energetically costly event 4,5 . How cells derive energy to resist mechanical force is unknown. Here, we show that application of force to E-cadherin stimulates liver kinase B1 (LKB1) to activate AMP-activated protein kinase (AMPK), a master regulator of energy homeostasis. LKB1 recruits AMPK to the E-cadherin mechanotransduction complex, thereby stimulating actomyosin contractility, glucose uptake and ATP production. The increase in ATP provides energy to reinforce the adhesion complex and actin cytoskeleton so that the cell can resist physiological forces. Together, these findings reveal a paradigm for how mechanotransduction and metabolism are linked and provide a framework for understanding how diseases involving contractile and metabolic disturbances arise.
In response to externally applied forces, cell surface adhesion receptors trigger robust actin cytoskeletal rearrangements and growth of the associated adhesion complex [1] [2] [3] . These changes are energetically costly, requiring approximately 50% of the total ATP in a cell 4, 5 . Energy homeostasis is controlled by AMP-activated protein kinase (AMPK). On the basis of this rationale, we tested whether application of force on E-cadherin increased AMPK activity. For this, a wellestablished approach to directly apply force to cadherins was employed [6] [7] [8] [9] [10] [11] [12] . Magnetic beads were coated with E-cadherin extracellular domains (or IgG as a control) and permitted to adhere to MCF10A epithelial cells. A constant force was then applied for 5 min using a permanent ceramic magnet. Following application of force, AMPK was immunoprecipitated and subjected to an in vitro kinase assay with a fusion protein of GST and a SAMS peptide (an AMPK-specific substrate) 13 . Application of force increased phosphorylation of the SAMS peptide by 4.9-fold; a control peptide (SAMA), lacking the second serine phosphorylation site, was not phosphorylated (Fig. 1a) . Importantly, the peptide phosphorylation was blocked by application of Compound C (a cell-permeable AMPK-specific inhibitor) 14 .
As additional measures of AMPK activation, we examined phosphorylation of AMPK in its activation loop and phosphorylation of the AMPK substrate, acetyl CoA carboxylase. Force increased phosphorylation of AMPK in its activation loop in MCF10A (pAMPK, Fig. 1b ) and MDCK II ( Supplementary Fig. 1a ) cells. The increases in activation loop phosphorylation were blocked when AMPK was inhibited using short hairpin RNAs (shRNAs; Fig. 1b ) or Compound C ( Supplementary Fig. 1a,b ). Phosphorylation of acetyl CoA carboxylase was also elevated ( Supplementary Fig. 1c ). Hence, by three independent measures, force stimulated AMPK activation.
To ensure that AMPK activation was independent of the method of force application, shear stress was applied to MDCK II cells using a parallel-plate chamber. Alternatively, junctional assembly was triggered using a calcium-switch assay-a process that relies on elevations in actin polymerization and myosin II activity 15, 16 . Both shear stress and junctional assembly stimulated AMPK activation loop phosphorylation ( Fig. 1c and Supplementary Fig. 1d ).
To interrogate the contribution of E-cadherin in force-induced AMPK activation, we examined the effects of inhibiting E-cadherin function using a function-blocking antibody (HECD-1) or by silencing E-cadherin expression ( Fig. 1d and Supplementary Fig. 1e ). E-cadherin was required to trigger AMPK activation ( Fig. 1d and Supplementary Fig. 1e ). Additionally, application of force to another transmembrane adhesion receptor, syndecan-1, failed to enhance AMPK phosphorylation ( Supplementary Fig. 1f ). Taken together, these data demonstrate force on E-cadherin stimulates AMPK activation.
To investigate the contribution of force to AMPK activation, we examined the effect of promoting and interfering with known mechanically controlled elements. To promote force transmission, increases in contractility were stimulated by applying calyculin A, a phosphatase inhibitor that augments myosin II phosphorylation.
Stimulating myosin light chain (MLC) phosphorylation increased AMPK activation ( Fig. 1e ). To interfere with force transmission, cells were treated with blebbistatin, a myosin II inhibitor. In the presence of blebbistatin, MLC phosphorylation and force-induced AMPK activation were decreased ( Fig. 1d ).
Since activated AMPK localizes to the plasma membrane 17 and E-cadherin is membrane-bound 18, 19 , we examined whether force stimulated AMPK recruitment to the cadherin adhesion complex. To address this possibility, we applied tensile forces to E-cadherin and assessed the levels of co-precipitating AMPK and activated AMPK. AMPK ( Fig. 1f ) and active AMPK (Fig. 1g ) were recovered with E-cadherin complexes. The recruitment of AMPK to E-cadherin was blocked by preincubation of the cells with blebbistatin ( Fig. 1f,g) , with E-cadherin function-blocking antibodies ( Fig. 1f ,g) or by silencing AMPK expression ( Supplementary Fig. 1g ). Additionally, the recruitment of AMPK to E-cadherin was not dependent on the method of force application as stimulating junctional assembly using a calcium-switch assay triggered AMPK co-immunoprecipitation with E-cadherin ( Supplementary Fig. 1h ). Taken together, these studies demonstrate that AMPK is recruited to E-cadherin in response to force.
How AMPK is activated and recruited to the cadherin complex was investigated. Previous studies indicated that LKB1, an AMPK activator, localizes to cadherin-containing complexes in maturing junctions 17 . Additionally calcium-induced tight junction assembly depends on LKB1 20 . On the basis of this rationale, we determined whether LKB1 associates with the cadherin adhesion complex in response to force. LKB1 was recovered with E-cadherin-coated magnetic beads in a force-and E-cadherin-dependent manner ( Fig. 2a ). Since the buffer conditions used to examine protein recruitment beneath the magnetic beads were less stringent than conventional co-immunoprecipitation studies, we examined whether LKB1 co-immunoprecipitated with E-cadherin. Robust co-immunoprecipitation of E-cadherin was observed in LKB1 immunoprecipitates recovered from cells lysed in a 1%-Triton X100containing buffer, thereby confirming the interaction (Fig. 2b) . In further support of LKB1, we determined whether LKB1 co-localized with E-cadherin in cells. Since the magnetic beads we use in these studies autofluoresce, we examined co-localization in response to application of shear stress to MDCK II cells. We observed strong co-localization of LKB1 and E-cadherin ( Fig. 2c ).
Having identified a mechanically active signalling pathway from E-cadherin to LKB1, we next determined whether LKB1 is required for AMPK activation and recruitment to the cadherin adhesion complex. Tensile forces were applied to E-cadherin on MCF10A ( Fig. 2d ) or on MDCK II ( Fig. 2e ) cells. We found that the force-induced activation of AMPK was prevented by LKB1 silencing in both cell lines ( Fig. 2d,e ). Similarly, shear-stress-induced activation of AMPK was blocked by inhibition of LKB1 ( Fig. 2f ). We next determined whether LKB1 was required for the recruitment of AMPK to E-cadherin. LKB1 inhibition prevented co-precipitation of AMPK and active AMPK with E-cadherin-coated magnetic beads ( Fig. 2g ). Taken together, these data demonstrate LKB1 is needed for AMPK to be recruited to and activated at cadherin-containing sites.
The observation that LKB1 and AMPK are recruited to the cadherin adhesion complex suggests that they may lie in a known contractility pathway. This pathway initiates when E-cadherin activates Abelson tyrosine kinase (Abl) thereby triggering phosphorylation of Tyr822 vinculin ( Fig. 3a ) and culminating in elevated RhoA-mediated contractility 11 . To determine whether LKB1 and/or AMPK are components of this pathway, we examined the effect of their inhibition. As an indicator of Abl activation, we followed phosphorylation of the Abl substrate, CrkL, using a phosphospecific antibody against the Abl-specific site 21 . Application of tensile forces using the magnetic bead approach stimulated CrkL phosphorylation in MCF10A (Fig. 3b ,c) and MDCK II cells ( Supplementary Fig. 2a ). Inhibition of LKB1 ( Fig. 3b and Supplementary Fig. 2a ) or AMPK ( Fig. 3c and Supplementary Fig. 2b ) prevented this increase. Stimulation of vinculin Tyr822 phosphorylation, a downstream target of Abl, also required LKB1 ( Fig. 3d ) and AMPK ( Fig. 3e and Supplementary Fig. 2c ). These data indicate that AMPK lies upstream of Abl in the known contractility pathway. Since Abl is activated and AMPK and vinculin are recruited to cadherin-containing junctions in response to force 22 , we examined whether AMPK is in a complex with these components. For this, we monitored co-immunoprecipitation of vinculin and Abl with AMPK from cells lysed in RIPA buffer. These studies revealed that AMPK forms a complex with Abl and vinculin in a force-dependent manner ( Fig. 3f ).
Further downstream in the E-cadherin contractility pathway ( Fig. 3a ), RhoA mediates activation of Rho kinase, which promotes phosphorylation of MLC, thereby stimulating actomyosin contractility 23 . We measured force-induced RhoA activity in cells in the presence or absence of LKB1 or AMPK. Application of tensile force to E-cadherin stimulated RhoA activation in an LKB1and AMPK-dependent manner ( Fig. 3g ). To determine whether increases in RhoA were propagated to changes in contractility, we analysed MLC phosphorylation at a regulatory Ser19 site 24 . MLC phosphorylation increased 2.7-fold in response to force ( Fig. 3h ). Inhibition of AMPK or LKB1 abrogated these effects (Fig. 3g,h and Supplementary Fig. 2d,e ). Taken together, these findings demonstrate that AMPK is required to increase RhoA-mediated contractility when E-cadherin experiences force.
These observations raise the question of why cells activate a master regulator of metabolism, such as AMPK, to modulate contractility. When cells experience force, elevations in enzymatic activity, actin polymerization, and actomyosin contractility facilitate the cytoskeletal rearrangements and the growth of adhesions necessary to withstand the force 2,25-28 . All of these processes require energy. The preferred energy source for epithelial cells is ATP derived from glucose oxidation 29 . In other systems, AMPK activation stimulates glucose uptake and oxidation 30 . On the basis of this rationale, we hypothesized that a consequence of force-induced AMPK is the stimulation of glucose uptake. To test this possibility, tensile forces were applied to E-cadherin and the uptake of a fluorescently labelled, non-hydrolysable 2deoxyglucose was monitored. Force stimulated a 2.2-fold increase in glucose uptake in the MCF10A cells ( Fig. 4a and Supplementary  Fig. 3a ) and a 2.6-fold increase in the MDCK II cells ( Fig. 4b and Supplementary Fig. 3b ). Moreover, inhibition of E-cadherin, LKB1 or AMPK prevented the force-induced glucose uptake (Fig. 4a,b and Supplementary Fig. 3a,b ). To ensure that these results were not the consequence of the approach, the effects of shear stress on MDCK II cells and the effects of stimulating junctional assembly (using a calcium-switch assay) were monitored. Both methods stimulated an elevation in glucose uptake. The fold activation was similar to the increase observed when tensile forces were applied ( Fig. 4c and Supplementary Fig. 3c,d) and required E-cadherin, LKB1 and AMPK. Collectively, these data demonstrate that force on E-cadherin stimulates glucose uptake in an LKB1-and AMPK-dependent manner.
In response to many stimuli, glucose is oxidized to ATP. Hence, we tested whether increases in glucose uptake translate to elevations in ATP. Application of force to E-cadherin increased cellular ATP levels by 1.5-fold ( Fig. 4d and Supplementary Fig. 3e ). The increase in ATP, while slight, was statistically significant ( Supplementary  Fig. 3e ). This modest change is not surprising as ATP levels remain relatively constant, even in the most metabolically active tissues 31 . Importantly, we found that force-induced ATP could be blocked by the shRNAs against LKB1 or AMPK ( Fig. 4d ), the AMPK inhibitor Compound C ( Fig. 4e and Supplementary Fig. 3f ), or the ATP synthase inhibitor oligomycin A ( Fig. 4e and Supplementary Fig. 3f ). To ensure that the ATP produced was derived from glucose, the effect of a non-hydrolysable, 2-deoxyglucose analogue was studied. The 2-deoxyglucose analogue blocked force-induced elevations in ATP ( Fig. 4e ). Taken together, these data indicate that the glucose taken up when E-cadherin experiences force is converted to ATP.
We next tested the possibility that ATP provides the energy necessary to reinforce the actin cytoskeleton and cadherin adhesion complex in response to force. In support of a role for AMPK, we found that A-769662, an AMPK activator, increased E-cadherin and F-actin enrichment in cell-cell junctions ( Supplementary Fig. 4a ). To directly test the role for LKB1 and AMPK, we applied shear stress to MCDK cells and monitored F-actin and E-cadherin enrichment in cell-cell junctions using immunofluorescence. A 2.0-fold increase in E-cadherin deposition in cell-cell junctions (Fig. 5a ,b) and a 3.8-fold increase in junctional actin were observed in cells exposed to shear stress ( Fig. 5a,c) . These increases were blocked by shRNAs against LKB1 or inhibitors of AMPK ( Fig. 5a-c) . Similarly, inhibiting glucose metabolism (by incubating cells in low-glucose-containing media) or blocking ATP synthesis (using oligomycin A or carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone) impaired junctional enrichment of F-actin and E-cadherin in shear-stress-treated cells ( Fig. 5a-c ). Only modest changes were observed in control cells ( Supplementary Fig. 4b-d ).
To ensure that shear stress applied force to cell-cell junctions, we investigated whether MLC was phosphorylated in response to shear and whether vinculin (an actin-binding protein that bears force) was enriched in cell-cell junctions. Both MLC phosphorylation and vinculin localization to cell-cell contacts were increased in response to shear stress ( Supplementary Fig. 4e-h) . In further support of a role for force, we found that the enrichment of vinculin in cell-cell junctions was blocked by preincubation of cells with blebbistatin (Supplementary Fig. 4e-g) . This observation is in agreement with previous findings showing that vinculin is recruited to endothelial cell-cell junctions in a tension-dependent manner 32 and force-dependent vinculin recruitment can be blocked by blebbistatin 22 . Collectively, these data demonstrate that AMPK-dependent increases in ATP enrich F-actin and E-cadherin in response to force.
Previous studies show that tension is required for the formation of an epithelial barrier 33 . To interrogate the physiological significance of the pathway uncovered in this study, the formation of an epithelial barrier was monitored in MDCK II cells after a calcium switch. After readdition of calcium to the medium, control cells gradually formed an epithelial barrier (Fig. 5d ). Inhibition of E-cadherin, LKB1, AMPK or myosin II compromised formation of the barrier function. By 24 h after junctional assembly was initiated, the cells with E-cadherin, LKB1 or AMPK inhibited had only modest (but statistically significant) alterations in their barriers (Fig. 5d ). Interestingly, a slight alteration in barrier function at 24 h after calcium readdition was observed in the MCDKII cells lacking E-cadherin. The requirement for AMPK is in agreement with previous studies showing that treatment of epithelial cells with AMPK activators promoted barrier function 34 . Taken together, these data indicate that forceinduced activation of LKB1/AMPK is required for efficient formation of an epithelial barrier.
Cell differentiation, proliferation, gene expression and disease development are all impacted by the forces experienced by the cell [35] [36] [37] [38] . A vast literature shows that cells withstand forces by reinforcing their actin cytoskeleton and growing their adhesion complex 1-3,26 . Figure 5 Force-induced increases in ATP reinforce the actin cytoskeleton and the E-cadherin adhesion complex to modulate barrier formation. (a-c) MDCK II cells (n = 80) or two clonal MDCK II cells lines (cl.11 and cl.14, n = 63 and 52 respectively) with LKB1 silenced were left untreated, treated with inhibitors of AMPK (Compound C (Cmpd.C), n = 62) or ATP synthesis (Oligo A, n = 44, or carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone (FCCP), n = 26), or incubated in lowglucose-containing media (Low gluc, n = 25). The cells were then left resting (no shear) or exposed to physiological shear stress. The cells were fixed, stained with antibodies against E-cadherin or Texas Red phalloidin, and examined by confocal microscopy (a). The graphs in b and c represent the average corrected fluorescence intensity of E-cadherin (b, E-cad) or F-actin (c) in junctions. The data are represented as a box and whisker plot with median, 10th, 25th, 75th and 90th percentiles shown. Scale bar, 20 µm. (d) MDCK II cells were grown to confluence and then incubated overnight in low-calcium-containing media. The formation of cell-cell junctions was then stimulated by adding growth media to the cells. The transepithelial resistance across the epithelial monolayer was monitored using a voltmeter at the indicated times (hours). The graph indicates the average ± s.e.m. for 3 independent experiments. * * , * and # indicate P values of <0.001, <0.01 and <0.05, respectively.
These events increase enzymatic activity, actin polymerization and actomyosin contractility [26] [27] [28] , yet it is unknown how the cell derives the vast amount of energy it needs to support these events. Here, we demonstrate that LKB1-mediated activation of AMPK is a key player in a junctional contractility pathway that increases glucose uptake and ATP synthesis. This is a mechanism for how cells signal to increase energy and use the energy to reinforce their cytoskeletal networks in order to resist applied forces.
This work establishes AMPK as a critical link between mechanotransduction and metabolism. This information may serve as the impetus for future studies aimed at establishing further links between mechanotransduction and the metabolic machinery and defining mechanisms of regulation. This work also has the potential to have far-reaching medical implications as AMPK is a negative regulator of disease states with metabolic disturbances. Our observation that E-cadherin force transmission activates AMPK demonstrates that mechanical forces on E-cadherin may protect against the metabolic disturbances associated with diseases such as cardiovascular disease 39 , diabetes 40 and cancer 38 .
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of this paper.
Note: Supplementary Information is available in the online version of the paper DOI: 10.1038/ncb3537 METHODS Cell lines. No cell lines used in this study were found in the database of commonly misidentified cell lines maintained by the ICLAD and NCBI. MCF10A human breast epithelial cells and MDCK II canine kidney epithelial cells were purchased from ATCC and were maintained as previously described 11, 41 . Cell lines were used for no more than twelve passages and were tested periodically for mycoplasma contamination (Lonzo MycoAlert). The cell lines were not authenticated. MDCK II lines expressing control shLuc, shLKB1 clones 11 and 14, and shEcadherin were described previously 17 . MDCK II cells were maintained in DMEM (4 g l −1 D-glucose with L-glutamine) with 10% FBS (Atlanta Biologicals) and 1× Penicillin/Streptomycin (Sigma). These lines were chosen for they are both nontumorigenic epithelial lines that form strong cell-cell adhesions that have been characterized by our laboratory and others 11, [41] [42] [43] . 293GPG cells are a virus-producing cell line that are a derivative of 293T cells and were maintained as described previously 11 .
Constructs. shRNA lentiviral particles targeting LKB1 and AMPK were purchased from Santa Cruz (270074-V labelled shLKB1, 29673-V denoted shAMPK1, and 45312-V termed shAMPK2). Additional control shRNA lentiviral particles containing scrambled AMPK targeting regions were purchased from Santa Cruz (108080, referred to as shControl). pLEGFP-vinculin Y822F was generated using site-specific mutagenesis of pLEGFP-WTvinculin 11, 42 . pGEX4T1-SAMS (aattccacatgaggtccgccatgtccggcttgcacctagtaaaacgacgac) and SAMA (aattccacatgaggtccgccatggccggcttgcacctagtaaaacgacgac) were generated by annealing oligonucleotides and ligating oligonucleotides into pGEX4T1 vector (GE Healthcare) cut at the Xho1 and EcoR1 restriction sites. pGEX-RBD was a generous gift from K. Burridge (University of North Carolina, USA).
Magnetic bead force assays. The application of tensile force to E-cadherin using magnetic beads was performed as previously described 11 . In brief, paramagnetic beads were coated with Fc-E-cadherin, IgG or syndecan-1 antibodies. For the E-cadherin-and IgG-coated beads, 1.5 mg Dynabeads Protein A (Invitrogen) were coated with 10 µg purified Fc-E-cadherin 44 or IgG. For the syndecan experiments, 0.75 µg protein G Dynabeads (Invitrogen) were coated with 10 µg syndecan-1 antibody (281.2; BD Biosciences). The beads were incubated with cells for 40 min at 37 • C in the presence or absence of Compound C (10 µM, Sigma), blebbistatin (50 µM, Sigma) or HECD-1 (200 µg ml −1 , Invitrogen). Tensile forces were applied to beads for 5-10 min using a permanent ceramic magnet. For all experiments, the magnet was placed parallel to and at a distance of 0.6 cm from the cell surface, so that the force on a single bead was approximately 10 pN (refs 6,11). After application of force, the cells were transferred to ice and immediately lysed.
Shear stress.
To examine the cellular response to shear stress, cells were grown to 90-95% confluence on 35 mm coverslips coated with 10 µg ml −1 fibronectin. Cells were placed in a parallel-plate flow chamber (Glycotech) and a Buchler polystatic pump was employed to apply force at 10 dyn cm −2 by administering media onto the cells at a rate of 3 ml min −1 . To determine force, the equation τ = 6 µQ/a 2 b (ref. 45 ) was used, where τ is the shear stress, dynes cm −2 , µ is the apparent viscosity of the media (DMEM-F12, 0.009598 poise or dynes × s cm −2 ), Q is the volumetric flow rate (3 ml min −1 ), a is the channel height (0.12 cm) and b is the channel width (2 cm). For signalling and cytoskeletal reinforcement studies, fluid was passed along the monolayer of cells for 6 h in the presence or absence of Compound C (Sigma, 10 µM), oligomycin A (Tocris, 10 µM), or carbonyl cyanide-4-(trifluoromethoxy)phenylhydrazone (FCCP, Sigma, 1 µM), or in low-glucose media (0.5 g l −1 D-glucose in DMEM). Cells were then immediately lysed in 2× Laemmli sample buffer or fixed in 4% paraformaldehyde. For glucose uptake assays, cells were exposed to shear stress for 2 h and then allowed to recover for 1 h with glucose derivative (2-NBDG).
Calyculin A treatment. Cells were grown to near confluence and treated with 5 nM calyculin A (Cell Signaling) for 40 min and then lysed.
Calcium-switch assays. The calcium-switch assays were performed by incubating cells in calcium-free media for 12 h and then restoring calcium-containing media for the times indicated.
AMPK in vitro kinase assay. Cells with and without force applied were lysed into an in vitro kinase assay buffer (50 mM Tris, pH 7.4, 50 mM NaF, 5 mM Na pyrophosphate, 1 mM EDTA, 1 mM EGTA, 250 mM mannitol, 1% (v/v) Triton X-100, 1 mM dithiothreitol). AMPK was immunoprecipitated from wholecell lysates using a 1:100 dilution of a polyclonal antibody against AMPK (Cell Signaling 2532), and the immunoprecipitates were washed with 50 mM Tris, pH 7.4, 150 mM NaCl, 50 mM NaF, 5 mM Na pyrophosphate, 1 mM EDTA, 1 mM EGTA.
GST-SAMS and GST-SAMA fusion proteins were purified according to the manufacturer's instructions. After elution, proteins were concentrated using the Amicon Ultra 3,000 MWCO system (Millipore). One microgram of purified SAMS and SAMA proteins were added to a kinase reaction mixture (1× Hepes-Brij buffer, 250 mM Na Hepes, pH 7.4, 5 mM dithiothreitol, 0.1%% Brij-35, 100 µM cold ATP, 300 µM AMP, 25 mM MgCl 2 and 10 µC i 32 P-ATP). Twenty microlitres of the reaction mixture was next added to 5 µl of washed protein A beads with bound AMPK. The reactions were incubated for 30 min at room temperature and stopped by adding 5× Laemmli sample buffer. The samples were boiled, analysed by SDS-PAGE and detected by autoradiography.
AMPK activator. Cells without force applied were treated with 100 µM of A-769662 (Selleck Chemical), which is a potent, reversible allosteric activator of AMPK. Cells were treated with the activator for 2 h and then fixed and stained for immunofluorescence.
Immunoprecipitation.
To immunoprecipitate E-cadherin or LKB1, cells were solubilized in extraction buffer (10 mM Tris-HCl, pH 7.6, 50 mM NaCl, 1% Triton X-100, 5 mM EDTA, 50 mM NaF, 20 µg ml −1 aprotinin, 2 mM Na 3 VO 4 and 1 mM phenylmethylsulfonyl fluoride). Clarified cell lysates were incubated with 6 µg of E-cadherin (HECD-1, Invitrogen) or a 1:100 dilution of a polyclonal LKB1 (Cell Signaling 27D10) antibody, and the resulting antibody complexes were recovered with Protein G or Protein A agarose (Sigma). To immunoprecipitate AMPK, cells were lysed in ice-cold RIPA buffer (50 mM Tris-HCl, pH 7.4, 1% NP-40, 0.5% Na-deoxycholate, 0.1% SDS, 150 mM NaCl, 2 mM EDTA, 50 mM NaF, 20 µg ml −1 aprotinin, 2 mM Na 3 VO 4 and 1 mM phenylmethylsulfonyl fluoride). Clarified lysates were incubated with a 1:100 dilution of a polyclonal antibody against AMPK (Cell Signaling 2532). The complexes were recovered with Protein A agarose (Sigma).
Pulldown assays.
Force was applied to cells using the magnetic bead approach described above with the exception that cells were pretreated for 2 h with 50 µM blebbistatin (Sigma) or 200 µg ml −1 HECD-1 (Invitrogen). Cells were lysed in icecold lysis buffer (20 mM Tris at pH 7.6, 150 mM NaCl, 0.1% NP-40, 2 mM MgCl 2 , 20 µg ml −1 aprotinin). Cadherin-coated beads were isolated from the lysate using a magnet and washed three times with lysis buffer. The bound proteins were denatured and reduced in 2× Laemmli sample buffer and separated using SDS-PAGE.
RhoA assays. Active RhoA (RhoA-GTP) was isolated using a GST fusion protein with a Rhotekin-binding domain (GST-RBD) as detailed previously 46 . The GST-RBD domain binds specifically to GTP-bound, but not GDP-bound, RhoA proteins 47 . Cells were lysed in 50 mM Tris (pH 7.6), 500 mM NaCl, 0.1% SDS, 0.5% DOC, 1% Triton X-100, MgCl 2 and rotated for 30 min with 30 µg of purified GST-RBD bound to glutathione-Sepharose beads. The beads were washed in 50 mM Tris (pH 7.6), 150 mM NaCl, 1% Triton X-100, 10 mM MgCl 2 and the bound proteins were separated using SDS-PAGE.
Immunoblotting. Cell lysates were fractionated by SDS-PAGE and transferred to PVDF (Immobilon). The membranes were blocked in 5% milk (vinculin, E-cadherin), 5% BSA (AMPK, pAMPK, ACC, pACC) or 1% BSA (pVinculin, pCrkL, CrkL, MLC, pMLC, Abl) and subjected to western blot analysis. AMPK was recognized using a polyclonal antibody from Cell Signaling (2532) that detects both the endogenous α-1 and α-2 isoforms of the catalytic subunit, but not the regulatory γ and β subunits. Phospho-AMPK was detected with an antibody that recognizes AMPK phosphorylated at Thr172 (Cell Signaling Technology, 40H9 2535 at 1:1,000 dilution). LKB1 was recognized with a polyclonal antibody from Cell Signaling (27D10 at 1:1,000 dilution). ACC was recognized with a polyclonal antibody from Cell Signaling (C83B10 at 1:1,000 dilution); phospho-ACC was detected with an antibody that recognizes ACC phosphorylated at Ser79 (Cell Signaling Technology, D7D11 at 1:1,000 dilution). Abl kinase was recognized using a polyclonal antibody raised against a peptide mapping the kinase domain from Santa Cruz (clone K-12, at 1:250 dilution). E-cadherin was detected with HECD-1 (Invitrogen 13-1700 at 1:1,000 dilution) or a monoclonal antibody from BD Transduction Labs at 1:1,000 dilution. Vinculin was detected with a monoclonal vinculin antibody (hVIN-1, Sigma at 1:1,000 dilution), and phosphorylated vinculin at Tyr822 was recognized with a rabbit polyclonal antibody (AB61071, Abcam at 1:1,000 dilution). CrkL was recognized with a polyclonal antibody raised against the C terminus of human CrkL (C-20, Santa Cruz Biotechnology at 1:250 dilution) and phospho-CrkL was immunoblotted with a polyclonal antibody that recognizes CrkL phosphorylated at Tyr207 (3181S, Cell Signaling Technology at 1:1,000 dilution). Phosphorylated myosin light chain (MLC) was detected with antibodies against phosphorylated Ser19 (3671, Cell Signaling at 1:1,000 dilution). MLC was also recognized with an antibody from Cell Signaling Technology (3672 at 1:1,000 dilution). The blots were visualized using chemoluminescence detection reagents (Pierce), and the signal was detected on X-ray film (Kodak) or a GE Image Quant LAS 400 Imager. Immunoblots were quantified using the ImageJ program, which measures the integrated density of bands corrected for background. Shown is the average ratio density from at least 3 experiments ± s.e.m. A series of two-tailed Student's t-tests, heteroscedastic variance, normal distribution, were performed to determine statistical significance.
Immunofluorescence. Cells were fixed in 4% paraformaldehyde in phosphatebuffered saline (PBS), permeabilized in 0.5% Triton X-100 in Universal buffer (UB) (150 mM NaCl, 50 mM Tris pH 7.6, 0.01% NaN 3 ) for 3 min, and washed in UB or PBS. Cells were blocked with 5% goat serum in UB for an hour at 37 • C, incubated with a primary antibody for 1 h at 37 • C, washed with UB, and then incubated with secondary antibody for 1 h at 37 • C. F-actin was stained using phalloidin conjugated with Texas Red at a 1:200 dilution (Life Technologies). E-cadherin was visualized by staining with HECD-1 (Invitrogen) at a 1:500 dilution, followed by FITC-conjugated goat anti-mouse IgG (H + L) (Jackson ImmunoResearch Laboratories) at a 1:500 dilution. To examine LKB1, cells were blocked in 1% BSA in UB and stained with LKB1 at 1:400 (Cell Signaling, 27D10). To examine vinculin localization, cells were blocked with 10% BSA in UB and stained with hVin-1(Sigma) and 7F9 (Millipore) at a 1:100 dilution, washed in UB and stained with an FITC-conjugated donkey antimouse IgG (H + L) at a 1:300 dilution (Jackson ImmunoResearch Laboratories). β-catenin (Sigma) was used at a 1:750 dilution and then incubated with Texas Redconjugated donkey anti-rabbit IgG (H + L) at a 1:500 dilution (Jackson ImmunoResearch Laboratories). Fluorescence images were captured at room temperature with a confocal microscope (model LSM 510; Carl Zeiss Micro Imaging). We used a 63× objective (Carl Zeiss Micro Imaging) with an NA of 1.2. Images were obtained using the LSM Image Browser (Carl Zeiss Micro Imaging). To examine vinculin the Leica SP8 confocal microscope was used with a 40× objective. Quantifications of images were made using ImageJ. Fifty junctions were measured at random over at least five fields of view. The data analyser was blinded to image identity. A Dixon Q-test 95% was used to determine whether data should be excluded. Graphs report the corrected fluorescence intensity of the regions of interest. The corrected fluorescence intensity = integrated density − background (area of measurement times the mean intensity). Data are represented as a box and whisker plot with the 90th-10th percentile shown. Fold increase in intensity was calculated from the average corrected fluorescence intensity divided by the corrected fluorescence intensity from the untreated samples and is depicted as the average of 3 independent experiments.
Glucose uptake assays. Glucose uptake was measured using a kit from Cayman Chemical (600470). To determine uptake in response to tensile forces, 1.0 × 10 5 cells per well were plated in 24-well plates and grown for two days. One hour prior to assay, cells were transferred to PBS with and without Compound C (10 µM, Sigma) or 200 µg ml −1 HECD-1 (Invitrogen). Fifty micrograms of Dynabeads Protein A (Invitrogen) coated in 0.4 µg Fc-E-cadherin or IgG were incubated with cells for 45 min at 37 • C. Just prior to applying force on cells, 33 µg of glucose derivative (2-NBDG) was added to each well. Force was applied to beads for 10 min, and then the cells were permitted to recover for 10 min at 37 • C and lysed in 250 µl of 10 mM Tris (pH 7.4), 50 mM NaCl, 5 mM EDTA, 50 mM NaF, 1% Triton X-100 and protease inhibitors. The lysates were centrifuged at 12,120g for 5 min at 4 • C, and the resulting supernatant (200 µl) was collected. An equal volume of Cell-Based Assay Buffer (Cayman Chemical, 10009322) was added to the collected supernatant. One hundred microlitres of resulting solution was loaded into a 96-well plate in triplicate, and a fluorescence reading at 485/535 nm was taken (Biotek Synergy Neo model NEOALHPA B, Gen 5 software). To evaluate uptake in response to junction formation, 1.0 × 10 5 cells per well were plated in 24-well plates and grown for 48 h in calcium-containing media. After 48 h, the cells were incubated in calcium-free media for 12 h and calcium was restored for the times indicated. The cells were lysed, and the amount of glucose uptake was measured as described above. The glucose uptake concentration was determined using a standard curve. Results are reported as micrograms per millilitre per 1 × 10 5 cells.
ATP assays. Cells were plated at a density of 0.75 × 10 5 for 2 days in 35 mm dishes. An hour before applying force, cells were treated with Compound C (Sigma 10 µM), oligomycin A (Tocris, 10 µM), 2-NBDG (fluorescently labelled 2-deoxyglucose from Cayman Chemical, 150 µg ml −1 ). Dynabeads (0.15 mg) coated with 1 µg of Fc-E-cadherin or IgG were incubated with the cells for 45 min. Force was applied using a ceramic magnet for 10 min. Intracellular ATP levels were examined using a Fluorometric ATP assay kit from Abcam (ab83355). Cells were lysed in 200 µl of ATP Assay Buffer, centrifuged at 12,000 r.p.m. for 5 min at 4 • C, and protein was removed from the supernatant using a 10 kD spin column (Thermo Scientific). Five microlitres of the de-proteinated sample was added to the ATP reaction mix in 96-well plates and a fluorescence reading at 535/587 nm was made (Biotek Synergy Neo model NEOALHPA B, Gen 5 software).
Transepithelial electrical resistance. Cells were plated on Costar 0.4 µm Polycarbonate membrane Transwell 24-well plates and grown to confluence. The cells were then incubated in calcium-free DMEM overnight. Growth medium was added back to the cultures for the indicated times and transepithelial electrical resistance was measured in triplicate using a Millipore Voltmeter (MERS 000 01). Results are in × cm 2 .
Statistics and reproducibility.
Statistical differences between groups of data were analysed using a series of two-tailed unpaired Student's t-tests. All experiments were completed at least three independent times. Key findings were repeated by at least two of the authors. Supplementary Figure 4 Controls for shear stress studies in Figure 5 . a-h, MDCK II cells (n=79) or two clonal MDCK II cells lines (cl.11 and cl.14, n=51 and 76 respectively) lacking LKB1 were left untreated, treated with inhibitors of AMPK (Compound C=Cmpd. C, n=55), treated with inhibitors of ATP synthesis (Oligo A,n=53 or Carbonyl cyanide-4-(trifluoromethoxy) phenylhydrazone =FCCP,n=29), treated with inhibitors of myosin II (blebbistatin=Blebbi, n=30), treated with the AMPK activator (A-769662), or incubated in low glucose containing media (Low Gluc, n=25). The cells were left resting (no shear) or exposed to shear stress (shear). a-d, The cells were fixed, stained with antibodies against E-cadherin or with Texas-Red labelled phalloidin, and visualized using confocal microscopy. Representative images are shown in a and d. Scale bars=20 μm. The 
